Modifying the current fee-for-service payment system for cancer therapy with feedback data and financial incentives that reward outcomes and cost efficiency resulted in a significant total cost reduction. Eliminating existing financial chemotherapy drug incentives paradoxically increased the use of chemotherapy.
No takes yet. Share an insight, caveat, or question.
Newcomer et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: